Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
1
25%
Ph not_applicable
3
75%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_1

A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

NCT07184086
completednot_applicable

Investigating the Physiological Effects of Weight Loss on Male Fertility

NCT03553927
completednot_applicable

Diabetes Intervention Accentuating Diet and Enhancing Metabolism

NCT03225339
completednot_applicable

Weight Loss Prior Mamma Reduction - A Pilot Study

NCT02659371

Clinical Trials (4)

Showing 4 of 4 trials
NCT07184086Phase 1

A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

Recruiting
NCT03553927Not Applicable

Investigating the Physiological Effects of Weight Loss on Male Fertility

Completed
NCT03225339Not Applicable

Diabetes Intervention Accentuating Diet and Enhancing Metabolism

Completed
NCT02659371Not Applicable

Weight Loss Prior Mamma Reduction - A Pilot Study

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4